Davis Polk advised Gilead, and Latham & Watkins advised the underwriters. Gilead Sciences, Inc. (Nasdaq: GILD) announced the pricing of senior unsecured notes in an aggregate...
Gilead’s $2 Billion Senior Unsecured Notes Offering
Korro Bio and Frequency Therapeutics’ Merger Agreement
Goodwin Procter is serving as legal counsel to Korro Bio, Latham & Watkins is serving as Frequency Therapeutics’ legal counsel, and Davis Polk is serving as...
Nordic Capital’s Investment Into Equashield
Latham & Watkins LLP represented Nordic Capital in the transaction. Nordic Capital, a leading private equity investor, and Equashield have announced that Nordic Capital has joined Equashield’s...
MeiraGTx’s Growth Financing Agreement with Perceptive Advisors
Latham & Watkins represented MeiraGTx in the transaction. MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage gene therapy company, announced a financing agreement with affiliates...
Amgen’s $3.7 Billion Acquisition of ChemoCentryx
Wachtell, Lipton, Rosen & Katz represented Amgen, while Latham & Watkins represented ChemoCentryx in the transaction. Amgen and ChemoCentryx, Inc., a biopharmaceutical company focused on orally...
BC Partners’ Acquisition of Havea
Latham & Watkins advised BC Partners. Jeausserand Audouard advised Havea Group. Kirkland & Ellis advised Funds advised by BC Partners on the financing of the acquisition....
Astorg’s Acquisition of CordenPharma
Freshfields Bruckhaus Deringer has advised International Chemical Investors Group on the deal, while Walder Wyss and Latham & Watkins advised Astorg. Milbank advised the management of...
Carlyle and PAI Partners’ Acquisition of Theramex
Linklaters and Allen & Overy advised global investment firms Carlyle and PAI Partners, while Latham & Watkins acted for CVC Capital Partners and Theramex. Taylor Wessing...
Waldencast’s $1.2 Billion Business Combination With Obagi and Milk Makeup
Skadden, Arps, Slate, Meagher & Flom represented Waldencast. Latham & Watkins, working alongside Conyers and Nixon Peabody, represented Obagi, and Goodwin Procter represented Milk Makeup in...
Minerva Surgical’s $75 Million Initial Public Offering
Latham & Watkins represented the underwriters in the transaction. Minerva Surgical, Inc. (Minerva Surgical), a women’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB),...